Cyclobenzaprine Hydrochloride
5 mg · Tablet, Film Coated
- Prescription only
- Muscle Relaxant
- Active substance
- Cyclobenzaprine Hydrochloride
- Used in
- Muscles, joints and bones
- Made by
- HAWAII REPACK, INC.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
This information is not included in the verified source. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Cyclobenzaprine Hydrochloride). It describes the substance, not this exact product.
Cyclobenzaprine HCl relieves skeletal muscle spasm of local origin without interfering with muscle function.
It is ineffective in muscle spasm due to central nervous system disease.
Cyclobenzaprine is extensively metabolized, and is excreted primarily as glucuronides via the kidney.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-07-08
Safety of the active substance
From the US prescribing label for the same active substance (Cyclobenzaprine Hydrochloride). It describes the substance, not this exact product.
- Hypersensitivity to any component of this product.
- Concomitant use of monoamine oxidase (MAO) inhibitors or within 14 days after their discontinuation.
- Hyperpyretic crisis seizures, and deaths have occurred in patients receiving cyclobenzaprine (or structurally similar tricyclic antidepressants) concomitantly with MAO inhibitor drugs.
- Acute recovery phase of myocardial infarction, and patients with arrhythmias, heart block or conduction disturbances, or congestive heart failure.
Most common adverse reactions in the 2 double-blind ‡, placebo-controlled 5 mg studies (incidence of > 3% on cyclobenzaprine HCl tablets, 5 mg): Adverse reactions which were reported in 1% to 3% of the patients were: abdominal pain, acid regurgitation, constipation, diarrhea, dizziness, nausea, irritability, mental acuity decreased, nervousness, upper respiratory infection, and pharyngitis.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
CanadaNo exact match for this strength and form
Details
| Made by | HAWAII REPACK, INC. |
|---|---|
| Active substance | Cyclobenzaprine Hydrochloride |
| Used in | Muscles, joints and bones |
| Strength | 5 mg |
| Form | Tablet, Film Coated |
| Route | Oral |
| Packs | 30 TABLET, FILM COATED in 1 BOTTLE · 60 TABLET, FILM COATED in 1 BOTTLE |
| NDC | 85534-0005 |
Source: NDC Directory · 2026-09-13 · not reviewed by a clinician
Source: US Food and Drug Administration, NDC Directory. Reuse terms: US government work (FDA).
Other strengths and forms
133 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- Tablet, Film Coated105 products
- Capsule, Extended Release22 products
- Tablet6 products
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.